HIDRADENITIS SUPPURATIVA (HS)
Clinical trials for HIDRADENITIS SUPPURATIVA (HS) explained in plain language.
Never miss a new study
Get alerted when new HIDRADENITIS SUPPURATIVA (HS) trials appear
Sign up with your email to follow new studies for HIDRADENITIS SUPPURATIVA (HS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Skin shots: new hope for painful skin condition?
Disease control Not yet recruitingThis study is testing a new method for treating a painful skin condition called Hidradenitis Suppurativa (HS). Researchers want to see if injecting an approved medication directly into the skin lesions works better and causes fewer side effects than the standard injection under t…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: PHASE4 • Sponsor: Peking Union Medical College • Aim: Disease control
Last updated Apr 02, 2026 03:56 UTC
-
Radiation zaps painful skin disease in new trial
Disease control Not yet recruitingThis study is testing whether a targeted course of radiation therapy can provide lasting relief for people with moderate to severe hidradenitis suppurativa (HS) that hasn't responded well to other treatments. Ten adult participants with HS in both armpits will receive radiation t…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New treatment tested for painful skin condition in china
Disease control Not yet recruitingThis study is testing a medication called secukinumab to see how well it works and how safe it is for Chinese adults with moderate-to-severe hidradenitis suppurativa (HS), a painful skin condition. It will follow 36 participants for about one year, comparing two different dosing …
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New laser study offers hope for painful skin condition
Disease control Not yet recruitingThis study aims to see if one type of laser treatment works as well as another for managing hidradenitis suppurativa (HS), a chronic skin condition. It will enroll 21 participants who have HS but are not on other strong medications. Researchers will compare how well each laser re…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: NA • Sponsor: Geisinger Clinic • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New shot tested for painful skin disease
Disease control Not yet recruitingThis study is testing an investigational drug called SCT650C for adults with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition that causes painful lumps. The main goal is to see if the drug can safely reduce the number of painful abscesses and nodules by …
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: PHASE2 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Hidden pain, real cost: study probes daily struggle of skin condition
Knowledge-focused Not yet recruitingThis study aims to better understand the real-life burden of hidradenitis suppurativa (HS), a painful and often misdiagnosed skin condition. It will observe 100 Canadian adults with HS to measure how the disease affects their work productivity, daily activities, pain levels, and …
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Sponsor: PeriPharm • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC
-
Scientists probe hidden immune clues in painful skin disease
Knowledge-focused Not yet recruitingThis research study aims to understand how a specific type of immune cell, called MAIT cells, is involved in hidradenitis suppurativa (HS), a chronic and painful skin condition. Researchers will compare blood and skin samples from 45 adults with moderate-to-severe HS to samples f…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC